Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Biohaven Pharmaceutical Holding Co Ltd. | a2235076zex-21_1.htm |
| EX-10.18 - EX-10.18 - Biohaven Pharmaceutical Holding Co Ltd. | a2235076zex-10_18.htm |
| EX-10.17 - EX-10.17 - Biohaven Pharmaceutical Holding Co Ltd. | a2235076zex-10_17.htm |
| EX-10.16 - EX-10.16 - Biohaven Pharmaceutical Holding Co Ltd. | a2235076zex-10_16.htm |
| EX-5.1 - EX-5.1 - Biohaven Pharmaceutical Holding Co Ltd. | a2235076zex-5_1.htm |
| S-1 - S-1 - Biohaven Pharmaceutical Holding Co Ltd. | a2235076zs-1.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 6, 2018 relating to the financial statements, which appears in Biohaven Pharmaceutical Holding Company Ltd.’s Annual Report on Form 10-K for the year ended December 31, 2017. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
|
/s/ PricewaterhouseCoopers LLP |
|
|
|
|
|
Hartford, Connecticut |
|
|
April 3, 2018 |
|